Lots of consolidation in the well overblown MJ stocks for sure. Way too high of prices for way too low of net nets in most companies that paid way too much for ancillary buyouts and taking on debt and dilutions... all in my own opinion of course.
On the CBD side I believe regulatory headwinds have had more to do with the sector than actual buildouts of companies specific to CBDs.
But both subsets of products are still gaining growth in use, CBDs eventually will get more growth imo.
Stil just got its sales going, don't know the ongoing costs for production for certain and how effective the B2B Broker Dealer networks will respond, but we should know pretty well in this quarter how going forward things will generally shake out.
I'm pretty sure at this point everyone is well aware the Canadian Stock Markets sell down any stock that isn't producing product and making sales...
We should see a reversal imo with a growing sales amounts. Have you been following legislations in the U.S.? Seems 'Novel Foods' applications are flooding into the E.U. Commission as well.
News 
Market Data 
Discover 
